Values as of: 2024-11-05
COMMON STOCK | Healthcare Plans |
Last Closing
USD 64.8Change
+0.98 (+1.54)%Market Cap
USD 32.42BVolume
6.21MAnalyst Target
USD 85.36Verdict
Verdict
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental and speech therapy services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.
Company Website : https://www.centene.com
Currency: USD
Country : USA
| Symbol | Name | Price(Change) | Market Cap |
|---|---|---|---|
| UNH | UnitedHealth Group Incorporate.. |
+9.26 (+1.66%) |
USD 521.40B |
| ELV | Elevance Health Inc |
-0.09 (-0.02%) |
USD 95.26B |
| MOH | Molina Healthcare Inc |
+2.73 (+0.83%) |
USD 18.62B |
| OSCR | Oscar Health Inc |
+0.25 (+1.38%) |
USD 4.12B |
| NEUE | NeueHealth Inc |
-0.02 (-0.40%) |
USD 0.05B |
| CI | Cigna Corp |
+6.07 (+1.94%) |
N/A |
| CVS | CVS Health Corp |
+0.69 (+1.26%) |
N/A |
| HUM | Humana Inc |
+5.05 (+1.98%) |
N/A |
| Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
|---|---|---|---|---|---|
| MVPA | Advisor Managed Portfolio.. | 7.70 % | 0.00 % |
+0.76 (+1.29%) |
USD 0.06B |
| AVDR | 2.70 % | 0.00 % |
N/A |
N/A | |
| DXSD:F | 2.30 % | 0.00 % |
N/A |
N/A | |
| DXSD:XETRA | 2.30 % | 0.00 % |
N/A |
N/A | |
| ABCS | Alpha Blue Capital US Sma.. | 1.58 % | 0.00 % |
+0.37 (+1.29%) |
USD 0.01B |
| FSYD | Fidelity Sustainable High.. | 0.04 % | 0.00 % |
+0.19 (+1.29%) |
USD 0.03B |
| FSBD | Fidelity Sustainable Core.. | 0.01 % | 0.00 % |
+0.25 (+1.29%) |
USD 0.01B |
| FHH:CA | First Trust AlphaDEX US H.. | 0.00 % | 0.77 % |
-0.21 (1.29%) |
CAD 0.01B |
| IHF | iShares U.S. Healthcare P.. | 0.00 % | 0.43 % |
+0.56 (+1.29%) |
N/A |
| ONEV | SPDR® Russell 1000 Low V.. | 0.00 % | 0.20 % |
+1.63 (+1.29%) |
N/A |
| JNKS:LSE | SSgA SPDR ETFs Europe I p.. | 0.00 % | 0.00 % |
-0.11 (1.29%) |
USD 0.18B |
| SYBK:F | SSgA SPDR ETFs Europe I p.. | 0.00 % | 0.00 % |
-0.24 (1.29%) |
USD 0.14B |
| SYBK:XETRA | SPDR Barclays 0-5 Year US.. | 0.00 % | 0.00 % |
-0.06 (1.29%) |
USD 0.13B |
| GBLO | 0.00 % | 0.00 % |
N/A |
N/A | |
| NVQ | 0.00 % | 0.00 % |
N/A |
N/A | |
| FHH-F:CA | First Trust AlphaDEX U.S... | 0.00 % | 0.00 % |
N/A |
CAD 0.01B |
| Market Performance vs. Industry/Classification (Healthcare Plans) | Market Performance vs. Exchange | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | -94.54% | 13% | F | 1% | F | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | -94.54% | 13% | F | 1% | F | ||
| Trailing 12 Months | |||||||
| Capital Gain | -94.36% | 13% | F | 1% | F | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | -94.36% | 13% | F | 1% | F | ||
| Trailing 5 Years | |||||||
| Capital Gain | -92.37% | 17% | F | 1% | F | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | -92.37% | 17% | F | 2% | F | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | 3.39% | 50% | F | 49% | F | ||
| Dividend Return | 3.39% | 38% | F | 40% | F | ||
| Total Return | N/A | N/A | N/A | N/A | N/A | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 24.75% | 50% | F | 43% | F | ||
| Risk Adjusted Return | 13.68% | 25% | F | 32% | F | ||
| Market Capitalization | 32.42B | 67% | D+ | 93% | A | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
The company had positive total cash flow in the most recent four quarters.
The company had positive total free cash flow in the most recent four quarters.
The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
